Table: begin end state 1 28 non-cytoplasmic 29 52 transmembrane 53 58 cytoplasmic 59 79 transmembrane 80 90 non-cytoplasmic 91 112 transmembrane 113 116 cytoplasmic 117 137 transmembrane 138 151 non-cytoplasmic 152 171 transmembrane 172 179 cytoplasmic 180 202 transmembrane 203 227 non-cytoplasmic 228 248 transmembrane 249 259 cytoplasmic 260 285 transmembrane 286 308 non-cytoplasmic 309 331 transmembrane 332 358 cytoplasmic 359 378 transmembrane 379 383 non-cytoplasmic 384 405 transmembrane 406 416 cytoplasmic 417 436 transmembrane 437 441 non-cytoplasmic 442 460 transmembrane 461 470 cytoplasmic
Input: >Ga0059261_1577 MAGGLFRTKRVKDAAEQAPEHRLAATLSWPHLVALGVGAIVGTGILTLIGVGAGKAGPAV IMSFVIAGAICACAALAYAEMATMMPASGSAYAYSYAVLGEIIAWVVGWSLILEYSLVVS TVAVGWSGYAAPLLHAWTGMPLELMAGPHANGIVNLPAIFIIAVVAGLLCLGTKESATLN AALVVVKIIALAVFVAVALPYFNGANLEPFAPFGFAKTISPDGVERGVMAAAAIIFFAFY GFDAISTAAEETKNPGRDLAIGIVGSMIACVAIYMLVAVAAVGATPFTHFANSPEPLALI LRDLGRPGFATFLAVSAIIALPTVLLGFLFGQSRIFFTMARDGMLPIGLAKVSKRGSPVR ITLFTAAIVAVIAGLLPIDEIAALANAGTLAAFTAVAVCMMVLRVRAPDMPRMFRTPLWW LVGAIAVLGCIYLFFSLPVKTQLWFLAWNALGVVIYFAYARPRVSAKGIE
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server